Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Subviral Agents01:29

Subviral Agents

940
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
940

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

P450 Electron transfer: Towards in vitro NAD(P)H-independent biocatalysis.

Journal of inorganic biochemistry·2025
Same author

Polyvalent Hybrid Virus-Like Nanoparticles with Displayed Heparin Antagonist Peptides.

Molecular pharmaceutics·2018
Same author

Heparin Binding to an Engineered Virus-like Nanoparticle Antagonist.

Biomacromolecules·2017
Same author

Electrochemical and structural characterization of Azotobacter vinelandii flavodoxin II.

Protein science : a publication of the Protein Society·2017
Same author

Heterogeneous catalysis for azide-alkyne bioconjugation in solution via spin column: Attachment of dyes and saccharides to peptides and DNA.

BioTechniques·2015
Same author

Bio-layer interferometry of a multivalent sulfated virus nanoparticle with heparin-like anticoagulant activity.

Analytical and bioanalytical chemistry·2015
Same journal

Analysis of End-Tidal CO2 Variability During Plateau Waves Episodes: An Information Theoretic Approach<sup></sup>.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same journal

AI and Tomosynthesis for Breast Cancer Molecular Subtyping: A step toward precision medicine<sup></sup>.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same journal

Towards Sustainable Protein Recovery from Biological Waste: Assessing Polyethersulfone-based Microfiltration.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same journal

Analysis of the cardiovascular response to standardized polymicrobial peritonitis experimental model.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same journal

Automated Wrist Ultrasound Image Bone Enhancement and Segmentation Using Deep Learning.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same journal

A Deep Learning approach for Depressive Symptoms assessment in Parkinson's disease patients using facial videos.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
See all related articles

Related Experiment Video

Updated: May 7, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.2K

Engineered virus-like nanoparticle heparin antagonists.

Andrew K Udit

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |October 11, 2013
    PubMed
    Summary
    This summary is machine-generated.

    Engineered bacteriophage Qβ nanoparticles show potent heparin antagonist activity. These virus nanoparticles offer a safe alternative to protamine, avoiding toxic side effects for potential clinical use.

    More Related Videos

    Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
    09:12

    Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

    Published on: May 11, 2018

    6.6K
    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
    09:29

    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

    Published on: October 29, 2015

    30.9K

    Related Experiment Videos

    Last Updated: May 7, 2026

    Engineering Antiviral Agents via Surface Plasmon Resonance
    13:00

    Engineering Antiviral Agents via Surface Plasmon Resonance

    Published on: June 14, 2022

    2.2K
    Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
    09:12

    Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

    Published on: May 11, 2018

    6.6K
    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
    09:29

    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

    Published on: October 29, 2015

    30.9K

    Area of Science:

    • Biotechnology
    • Nanotechnology
    • Virology

    Background:

    • Virus nanoparticles are versatile platforms for presenting epitopes.
    • Heparin antagonists are crucial in clinical settings, but current options like protamine have toxic side effects.

    Purpose of the Study:

    • To engineer bacteriophage Qβ nanoparticles as potent heparin antagonists.
    • To develop a safer alternative to existing heparin antagonist drugs.

    Main Methods:

    • Chemically appending poly-Arg peptides to Qβ nanoparticles.
    • Introducing point mutations to create Arg on the virus capsid.
    • Displaying heparin-binding peptides externally on the virus surface.

    Main Results:

    • All three engineered Qβ nanoparticle approaches demonstrated significant heparin antagonist activity.
    • The developed nanoparticles exhibited no toxic side effects associated with protamine.

    Conclusions:

    • Engineered bacteriophage Qβ nanoparticles are effective heparin antagonists.
    • These nanoparticles represent a promising, safer alternative to protamine for clinical applications.